94K-29353-75752
3 vaccinations
10 coded responses
38 check-ins
10 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 600 / IL
- Registered
- 2021-03-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-10
Dose 1 — Moderna
-
2021-03-11
Registered in v-safe
-
2021-03-11
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain, Swelling, Itching · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-12
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Itching · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling, Itching · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-15
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Itching · Fatigue or tirednessAdult check-in
-
2021-03-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-17
- 2021-03-24
- 2021-03-31
-
2021-04-07
Dose 2 — Moderna
-
2021-04-07
Health check-in — day 0, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-04-08
Survey response — days 1–6 daily, dose 2MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Site: Pain, Itching · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Stuffy and runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Fatigue or tirednessAdult check-in
-
2021-04-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Fatigue or tirednessAdult check-in
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-04-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-14
- 2021-04-21
-
2021-04-28
Survey response — day 21, dose 2MedDRA: Injection site pain, Intermenstrual bleeding, Weight increased — Feeling: GoodFree text: Spotty period, weight gain, continued intermittent pain at the injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-05
Survey response — day 28, dose 2MedDRA: Intermenstrual bleeding, Menstrual disorder — Feeling: GoodFree text: Spotting/unusual periodMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-12
Survey response — day 35, dose 2MedDRA: Intermenstrual bleeding — Feeling: GoodFree text: Spotting and abnormal periodMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-20
Survey response — day 42, dose 2MedDRA: Injection site pain, Menstruation irregular, Vaginal haemorrhage — Feeling: GoodFree text: Spotting and irregular period. Random pain at injection site.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-07
Survey response — 3 months, dose 2MedDRA: Contraception, Intermenstrual bleeding, Menstruation irregular — Feeling: GoodFree text: Spotting and inconsistent periods while on birth controlMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-10-08
Survey response — 6 months, dose 2MedDRA: Menstruation irregular — Feeling: PoorFree text: Period has been inconsistentMedDRA releases: 2024-11 · check-in free text available
-
2021-12-10
Dose 3 — Moderna
-
2021-12-10
Health check-in — day 0, dose 3Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2021-12-11
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-12
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-12-13
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Itching · Headache, Muscle or body achesAdult check-in
-
2021-12-14
Survey response — days 1–6 daily, dose 3MedDRA: Insomnia — Feeling: Fair · Muscle or body aches, Fatigue or tirednessFree text: InsomniaMedDRA releases: 2024-11 · check-in free text available
-
2021-12-15
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fever · Headache · Be unable to work or attend schoolAdult check-in
- 2021-12-17
- 2021-12-24
- 2021-12-31
- 2022-01-07
-
2022-01-14
Survey response — day 35, dose 3MedDRA: Malaise, SARS-CoV-2 test positive — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Have been diagnosed/tested positive with COVID and all of the full fledged associated symptoms of the Omnicrom variant.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-21
Survey response — day 42, dose 3MedDRA: Malaise, Menstrual disorder — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Menstruation is out of the ordinary + COVID symptomsMedDRA releases: 2024-11 · check-in free text available
- 2022-03-11
- 2022-06-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-10 | Moderna | |
| 2 | 2021-04-07 | Moderna | |
| 3 | 2021-12-10 | Moderna | No |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Stuffy and runny nose
Release 8 — day 21, dose 2
Symptoms: Spotty period, weight gain, continued intermittent pain at the injection site
Release 8 — day 28, dose 2
Symptoms: Spotting/unusual period
Release 8 — day 35, dose 2
Symptoms: Spotting and abnormal period
Release 8 — day 42, dose 2
Symptoms: Spotting and irregular period. Random pain at injection site.
Release 9 — 3 months, dose 2
Symptoms: Spotting and inconsistent periods while on birth control
Release 10 — 6 months, dose 2
Symptoms: Period has been inconsistent
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Insomnia
Release 10 — day 35, dose 3
Symptoms: Have been diagnosed/tested positive with COVID and all of the full fledged associated symptoms of the Omnicrom variant.
Release 11 — day 42, dose 3
Symptoms: Menstruation is out of the ordinary + COVID symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Contraception | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Intermenstrual bleeding | ✓ | ✓ | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Menstrual disorder | ✓ | ✓ | ✓ |
| SD | Menstruation irregular | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Vaginal haemorrhage | ✓ | ✓ | ✓ |
| SD | Weight increased | ✓ | ✓ | ✓ |
| SRO | Insomnia | · | · | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release